Caris Life Sciences (CAI) Senior VP & GC John Russel Sells 7,500 Shares

What Happened John Russel, Senior Vice President, General Counsel, and Secretary of Caris Life Sciences, sold 7,500 shares of CAI stock in an open-market transaction on September 22, 2026. The shares were sold at a weighted average price of $31.82 per share for aggregate proceeds of approximately $238,626. This was a sale (disposition) of shares, which is typically a routine liquidity transaction and not by itself an indicator of company performance.

Key Details

• Transaction date: 2026-09-22 (Form 4 filed 2026-09-23).
• Transaction type: Open-market sale (Code S).
• Price: Weighted average $31.82; actual trade prices ranged from $31.7750 to $31.8700 (sold in multiple transactions).
• Proceeds: Approximately $238,626 for 7,500 shares.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnotes: F1 notes the weighted-average price and offers to provide a breakdown of shares sold at each price within the stated range. F2 notes inclusion of shares acquired under the 2025 Employee Stock Purchase Plan since the prior Form 4.
• Filing timeliness: Form 4 was filed the day after the transaction (9/23/2026 for a 9/22/2026 trade), consistent with typical insider reporting timing.

Context This was a straightforward open-market sale by a senior officer (not identified as a 10% owner). Sales by executives can be routine (liquidity, diversification, tax needs) and do not by themselves signal company performance. No options were exercised and no gifts or complex derivative transactions are involved in this reported activity.